Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis  Nauman Siddiqi, Maureen A. McBride,

Slides:



Advertisements
Similar presentations
Volume 62, Issue 2, Pages (August 2002)
Advertisements

Volume 54, Issue 2, Pages (August 1998)
Living unrelated donor kidney transplantation
Volume 83, Issue 3, Pages (March 2013)
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
Volume 82, Issue 5, Pages (September 2012)
Adhesion molecule polymorphisms in chronic renal allograft failure
Volume 83, Issue 2, Pages (February 2013)
Volume 84, Issue 3, Pages (September 2013)
Subclinical rejection in renal transplants is associated with low serum mannose-binding lectin levels  Meritxell Ibernon, Francesc Moreso, Daniel Serón 
Volume 94, Issue 4, Pages (October 2018)
Volume 80, Issue 10, Pages (November 2011)
Progression of renal failure and hypertensive nephrosclerosis
Volume 57, Issue 5, Pages (May 2000)
Volume 79, Issue 6, Pages (March 2011)
Better nephrology for mice—and man
Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?  Fu L. Luan, Diane E. Steffick,
End-stage renal disease in living kidney donors
Comorbidity and confounding in end-stage renal disease
Living unrelated donor kidney transplantation
Lipid redistribution in renal dysfunction
Volume 70, Issue 11, Pages (December 2006)
Kamila Czene, Ph.D., Kari Hemminki  Kidney International 
Stephen P. McDonald  Kidney International Supplements 
Volume 87, Issue 2, Pages (February 2015)
Volume 71, Issue 6, Pages (March 2007)
Volume 70, Issue 12, Pages (December 2006)
Fructose intake as a risk factor for kidney stone disease
Volume 62, Issue 1, Pages (July 2002)
Should kidney donors be genotyped for APOL1 risk alleles?
Volume 89, Issue 5, Pages (May 2016)
Volume 66, Issue 2, Pages (August 2004)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 62, Issue 5, Pages (November 2002)
Kai Singbartl, John A. Kellum  Kidney International 
Volume 64, Issue 3, Pages (September 2003)
Counteracting progression of renal disease: A look into the future
Volume 56, Issue 5, Pages (November 1999)
Volume 58, Issue 6, Pages (December 2000)
Volume 84, Issue 4, Pages (October 2013)
Volume 71, Issue 12, Pages (June 2007)
Volume 87, Issue 5, Pages (May 2015)
Homocysteine, renal function, and risk of cardiovascular disease
Volume 73, Issue 9, Pages (May 2008)
Volume 63, Issue 2, Pages (February 2003)
Long-term survival in renal transplant recipients with graft function
Post-transplant hypophosphatemia: Tertiary ‘Hyper-Phosphatoninism’?
Racial differences in survival of patients on dialysis
Volume 74, Issue 9, Pages (November 2008)
Organ transplantation goes to the movies
Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant  Chirag R. Parikh, Peter Mcsweeney,
Does equal care give equal outcomes?
Stephen P. Mcdonald, Graeme R. Russ  Kidney International 
Volume 62, Issue 2, Pages (August 2002)
The Danish Renal Biopsy Register
Volume 80, Issue 10, Pages (November 2011)
BK virus nephritis after renal transplantation
Charles A. Herzog  Kidney International 
Volume 53, Issue 5, Pages (May 1998)
Volume 55, Issue 2, Pages (February 1999)
Volume 70, Issue 5, Pages (September 2006)
Volume 62, Issue 2, Pages (August 2002)
Volume 64, Issue 4, Pages (October 2003)
The international realities of live donor kidney transplantation
Global trends in the rates of living kidney donation
Kevin C. Abbott, Robert J. Oglesby, Lawrence Y. Agodoa 
Volume 57, Pages S44-S48 (April 2000)
Ronen Levi, Justin Silver  Kidney International 
Volume 68, Issue 4, Pages (October 2005)
Presentation transcript:

Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis  Nauman Siddiqi, Maureen A. McBride, Sundaram Hariharan  Kidney International  Volume 65, Issue 5, Pages 1906-1913 (May 2004) DOI: 10.1111/j.1523-1755.2004.00589.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Post 1-year actuarial kidney graft survival for living donor grafts without (A) and with (B) censoring for death with a functioning graft according to 1year serum creatinine (≤1.5mg/dL and >1.5mg/dL). Kidney International 2004 65, 1906-1913DOI: (10.1111/j.1523-1755.2004.00589.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Post 1-year actuarial kidney graft survival for cadaver donor grafts without (A) and with (B) censoring for death with a functioning graft according to 1year serum creatinine (≤1.5mg/dL and >1.5mg/dL). Kidney International 2004 65, 1906-1913DOI: (10.1111/j.1523-1755.2004.00589.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Projected median kidney graft half-life in years, for living donor (A) and cadaver donor (B) kidney grafts according to 1-year serum creatinine (≤1.5mg/dL and >1.5mg/dL) with and without censoring for death with a functioning graft. Kidney International 2004 65, 1906-1913DOI: (10.1111/j.1523-1755.2004.00589.x) Copyright © 2004 International Society of Nephrology Terms and Conditions